Steven E Nissen, Kathy Wolski. N Engl J Med 2007
Times Cited: 2870
Times Cited: 2870
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull, Christopher P Cannon, George Capuano, Pei-Ling Chu, Dick de Zeeuw, Tom Greene, Adeera Levin, Carol Pollock, David C Wheeler, Yshai Yavin, Hong Zhang, Bernard Zinman, Gary Meininger, Barry M Brenner, Kenneth W Mahaffey. N Engl J Med 2019
Times Cited: 1050
Times Cited: 1050
List of shared articles
Times cited
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Are They All the Same? A Narrative Review of Cardiovascular Outcome Trials.
David M Williams, Asif Nawaz, Marc Evans. Diabetes Ther 2021
David M Williams, Asif Nawaz, Marc Evans. Diabetes Ther 2021
SGLT-2 inhibitors may be targeting higher risk patients with diabetes possibly justifying higher cost: Single center repeated cross-sectional analysis.
Larry A Weinrauch, Jiankang Liu, Alissa R Segal, Jason Woodward, John A D'Elia. J Diabetes Complications 2021
Larry A Weinrauch, Jiankang Liu, Alissa R Segal, Jason Woodward, John A D'Elia. J Diabetes Complications 2021
Type 2 Diabetes and Myocardial Infarction: Recent Clinical Evidence and Perspective.
Jing Cui, Yanfei Liu, Yiwen Li, Fengqin Xu, Yue Liu. Front Cardiovasc Med 2021
Jing Cui, Yanfei Liu, Yiwen Li, Fengqin Xu, Yue Liu. Front Cardiovasc Med 2021
Antihyperglycemic therapies and cardiovascular outcomes in patients with type 2 diabetes mellitus: State of the art and future directions.
Eri Toda Kato, Sandeep R Das, Darren K McGuire. Trends Cardiovasc Med 2021
Eri Toda Kato, Sandeep R Das, Darren K McGuire. Trends Cardiovasc Med 2021
Second revolution in cardiovascular prevention.
Chern-En Chiang, Kang-Ling Wang, Hao-Min Cheng, Shih-Hsien Sung, Tze-Fan Chao. J Chin Med Assoc 2020
Chern-En Chiang, Kang-Ling Wang, Hao-Min Cheng, Shih-Hsien Sung, Tze-Fan Chao. J Chin Med Assoc 2020
Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseases.
Nikolaus Marx, Lars Rydén, Frank Brosius, Antonio Ceriello, Michael Cheung, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod,[...]. Diabetes Res Clin Pract 2020
Nikolaus Marx, Lars Rydén, Frank Brosius, Antonio Ceriello, Michael Cheung, Francesco Cosentino, Jennifer Green, Monika Kellerer, Susan Koob, Mikhail Kosiborod,[...]. Diabetes Res Clin Pract 2020
Diabetes and coronary artery disease: not just a risk factor.
Peter J Grant, Francesco Cosentino, Nikolaus Marx. Heart 2020
Peter J Grant, Francesco Cosentino, Nikolaus Marx. Heart 2020
Non-insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials.
Gianluigi Savarese, Benedikt Schrage, Francesco Cosentino, Lars H Lund, Giuseppe M C Rosano, Petar Seferovic, Javed Butler. ESC Heart Fail 2020
Gianluigi Savarese, Benedikt Schrage, Francesco Cosentino, Lars H Lund, Giuseppe M C Rosano, Petar Seferovic, Javed Butler. ESC Heart Fail 2020
Cardiovascular safety outcomes of once-weekly GLP-1 receptor agonists in people with type 2 diabetes.
Jennifer D Goldman. J Clin Pharm Ther 2020
Jennifer D Goldman. J Clin Pharm Ther 2020
Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?
Ehtasham Ahmad, Jack A Sargeant, Francesco Zaccardi, Kamlesh Khunti, David R Webb, Melanie J Davies. Pharmaceuticals (Basel) 2020
Ehtasham Ahmad, Jack A Sargeant, Francesco Zaccardi, Kamlesh Khunti, David R Webb, Melanie J Davies. Pharmaceuticals (Basel) 2020
Can the cardiovascular risk reductions observed with empagliflozin in the EMPA-REG OUTCOME trial be explained by concomitant changes seen in conventional cardiovascular risk factor levels?
Ruth L Coleman, Alastair M Gray, Uli C Broedl Md, David Fitchett, Jyothis T George, Hans J Woerle, Bernard Zinman, Rury R Holman. Diabetes Obes Metab 2020
Ruth L Coleman, Alastair M Gray, Uli C Broedl Md, David Fitchett, Jyothis T George, Hans J Woerle, Bernard Zinman, Rury R Holman. Diabetes Obes Metab 2020
Diabetic Agents, From Metformin to SGLT2 Inhibitors and GLP1 Receptor Agonists: JACC Focus Seminar.
Tanya Wilcox, Christophe De Block, Arthur Z Schwartzbard, Jonathan D Newman. J Am Coll Cardiol 2020
Tanya Wilcox, Christophe De Block, Arthur Z Schwartzbard, Jonathan D Newman. J Am Coll Cardiol 2020
RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020.
Rajeev Chawla, S V Madhu, B M Makkar, Sujoy Ghosh, Banshi Saboo, Sanjay Kalra. Indian J Endocrinol Metab 2020
Rajeev Chawla, S V Madhu, B M Makkar, Sujoy Ghosh, Banshi Saboo, Sanjay Kalra. Indian J Endocrinol Metab 2020
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes Mellitus: Lessons Learned and Future Directions.
Abhinav Sharma, Neha J Pagidipati, Robert M Califf, Darren K McGuire, Jennifer B Green, Dave Demets, Jyothis Thomas George, Hertzel C Gerstein, Todd Hobbs, Rury R Holman,[...]. Circulation 2020
Abhinav Sharma, Neha J Pagidipati, Robert M Califf, Darren K McGuire, Jennifer B Green, Dave Demets, Jyothis Thomas George, Hertzel C Gerstein, Todd Hobbs, Rury R Holman,[...]. Circulation 2020
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) for cardiovascular outcomes in type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials.
Tobias Täger, Dan Atar, Stefan Agewall, Hugo A Katus, Morten Grundtvig, John G F Cleland, Andrew L Clark, Hanna Fröhlich, Lutz Frankenstein. Heart Fail Rev 2020
Tobias Täger, Dan Atar, Stefan Agewall, Hugo A Katus, Morten Grundtvig, John G F Cleland, Andrew L Clark, Hanna Fröhlich, Lutz Frankenstein. Heart Fail Rev 2020
2020 Consensus of Taiwan Society of Cardiology on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases.
Chern-En Chiang, Kwo-Chang Ueng, Ting-Hsing Chao, Tsung-Hsien Lin, Yih-Jer Wu, Kang-Ling Wang, Shih-Hsien Sung, Hung-I Yeh, Yi-Heng Li, Ping-Yen Liu,[...]. J Chin Med Assoc 2020
Chern-En Chiang, Kwo-Chang Ueng, Ting-Hsing Chao, Tsung-Hsien Lin, Yih-Jer Wu, Kang-Ling Wang, Shih-Hsien Sung, Hung-I Yeh, Yi-Heng Li, Ping-Yen Liu,[...]. J Chin Med Assoc 2020
Insulin: Trigger and Target of Renal Functions.
Ana F Pina, Diego O Borges, Maria João Meneses, Patrícia Branco, Rita Birne, Antonio Vilasi, Maria Paula Macedo. Front Cell Dev Biol 2020
Ana F Pina, Diego O Borges, Maria João Meneses, Patrícia Branco, Rita Birne, Antonio Vilasi, Maria Paula Macedo. Front Cell Dev Biol 2020